Vekta Innovations

29/05/2026

𝗨𝗣𝗗𝗔𝗧𝗘: 𝗗𝗿𝗮𝘀𝘁𝗶𝗰 𝗡𝗲𝘂𝗿𝗼𝗺𝘂𝘀𝗰𝘂𝗹𝗮𝗿 𝗥𝗲𝗽𝗮𝗶𝗿 𝗮𝗻𝗱 𝗙𝘂𝗻𝗰𝘁𝗶𝗼𝗻

Received this message yesterday [27 May 2026]:
“I went to my neurology appointment today, which constitutes the bulk of my condition, and they mentioned that there has been drastic upper-body improvement. My mom mentioned the machine, and they said I should continue because I’ve improved since last year April.”

She has Spinal Muscular Atrophy (SMA) Type 3 and has been doing once-weekly KineDek AI-CRT sessions since 17 June 2025. The following has been observed over the past 11 months:
- significant lean muscle growth where there was previously only flaccidity and muscle wasting
- ability to use a standard wheelchair, which was not possible at the previous assessment
- improvements in standing ability
- major improvements in overall body comfort, including the absence of chronic pain
- spinal straightening and improved postural support
- improved energy and well-being

It should be noted that SMA (Spinal-Muscular Atrophy) is a progressive degenerative disease marked by ongoing neuromuscular decline, and this pattern of deterioration had been consistent for 17 years. The above now demonstrates a sustained and measurable reversal in function, strength, and structural support over the past 11 months with once-weekly KineDek AI-CRT intervention.

Most notably, specialists who had previously indicated that corrective spinal surgery was becoming imminent have now stated that surgery is no longer necessary at this stage.

The next major objective over the coming year is to continue rebuilding lower-body and leg strength in the lead-up to her 21st birthday on 17 August 2027, with the hope of restoring enough lower-limb function and stability to achieve full physical independence.

While this remains a representative, hypothesis-generating case, the degree of neuromuscular improvement being observed in a long-term genetic muscle-wasting condition is highly noteworthy.

🌐 VEKTA.NET

16/05/2026

𝗔 𝗠𝗲𝘁𝗮𝗯𝗼𝗹𝗶𝗰 𝗣𝗮𝗿𝗮𝗱𝗶𝗴𝗺 𝗦𝗵𝗶𝗳𝘁 𝗧𝗵𝗮𝘁 𝗖𝗼𝘂𝗹𝗱 𝗔𝗳𝗳𝗲𝗰𝘁 𝗛𝗮𝗹𝗳 𝘁𝗵𝗲 𝗪𝗼𝗿𝗹𝗱'𝘀 𝗣𝗼𝗽𝘂𝗹𝗮𝘁𝗶𝗼𝗻

A striking metabolic pattern is emerging globally — and it may be far more widespread than previously recognised.

The so-called “thin-fat” or TOFI (“thin outside, fat inside”) phenotype, which differs markedly from the typical Western obesity pattern, has long been associated with South Asian populations. However, it is increasingly being identified across diverse populations worldwide. Individuals may present with a normal BMI and appear relatively healthy, yet carry high levels of visceral fat, insulin resistance, chronic inflammation, and significant underlying metabolic dysfunction.

What makes this particularly interesting is not just the phenotype — but what happens when the system is challenged differently.

In a severe case example involving a 70-year-old male of South Indian origin with chronic gout and significant central obesity, a once-weekly 20-minute AI-CRT intervention was associated with rapid shifts in body composition, resolution of gout symptoms, and marked improvements in overall physical function — without any reported dietary change.

If this pattern holds under further observation, it raises important questions about how we define “effective exercise” in metabolically compromised populations.

𝘐𝘴 𝘪𝘵 𝘱𝘰𝘴𝘴𝘪𝘣𝘭𝘦 𝘵𝘩𝘢𝘵 𝘤𝘦𝘳𝘵𝘢𝘪𝘯 𝘧𝘰𝘳𝘮𝘴 𝘰𝘧 𝘳𝘦𝘴𝘪𝘴𝘵𝘢𝘯𝘤𝘦 𝘵𝘳𝘢𝘪𝘯𝘪𝘯𝘨 𝘤𝘢𝘯 𝘳𝘦𝘱𝘳𝘰𝘨𝘳𝘢𝘮 𝘮𝘦𝘵𝘢𝘣𝘰𝘭𝘪𝘤 𝘩𝘦𝘢𝘭𝘵𝘩 𝘮𝘰𝘳𝘦 𝘦𝘧𝘧𝘪𝘤𝘪𝘦𝘯𝘵𝘭𝘺 𝘵𝘩𝘢𝘯 𝘸𝘦 𝘤𝘶𝘳𝘳𝘦𝘯𝘵𝘭𝘺 𝘶𝘯𝘥𝘦𝘳𝘴𝘵𝘢𝘯𝘥?

🌐 VEKTA.NET

A Severe Gout and Central Obesity Case Highlights the Potential of KineDek AI-CRT One of the most striking metabolic phenotypes observed glo...

08/05/2026

𝗨𝗽𝗱𝗮𝘁𝗲 𝗼𝗻 𝗘𝗻𝗱 𝗦𝘁𝗮𝗴𝗲 (𝟱-𝟭𝟬% 𝗳𝘂𝗻𝗰𝘁𝗶𝗼𝗻) 𝗞𝗶𝗱𝗻𝗲𝘆 𝗗𝗶𝘀𝗲𝗮𝘀𝗲 𝗖𝗮𝘀𝗲

Groote Schuur Hospital has indicated that the individual who was initially deemed terminal with end-stage kidney disease now presents with relatively normal kidney function eight months later.

This case can be verified by contacting the attending doctors at Groote Schuur Hospital, Cape Town.

🌐 VEKTA.NET

Preamble The following scenario was presented to ChatGPT: In an advanced case of end-stage kidney disease following intense chemother...

07/04/2026

𝗪𝗵𝗲𝗻 𝗗𝗮𝗶𝗹𝘆 𝗩𝗶𝘀𝗶𝗼𝗻 𝗟𝗼𝘀𝘀 𝗗𝗶𝘀𝗮𝗽𝗽𝗲𝗮𝗿𝘀 — 𝗮𝗻𝗱 𝗪𝗵𝗮𝘁 𝗜𝘁 𝗠𝗮𝘆 𝗥𝗲𝘃𝗲𝗮𝗹 𝗔𝗯𝗼𝘂𝘁 𝗘𝘆𝗲 𝗛𝗲𝗮𝗹𝘁𝗵 𝗠𝗼𝗿𝗲 𝗕𝗿𝗼𝗮𝗱𝗹𝘆

In our previous post, “𝘞𝘩𝘺 𝘕𝘦𝘤𝘬 𝘢𝘯𝘥 𝘚𝘩𝘰𝘶𝘭𝘥𝘦𝘳 𝘔𝘰𝘷𝘦𝘮𝘦𝘯𝘵 𝘐𝘴 𝘵𝘩𝘦 𝘙𝘦𝘢𝘭 ‘𝘗𝘶𝘮𝘱’ 𝘧𝘰𝘳 𝘵𝘩𝘦 𝘉𝘳𝘢𝘪𝘯 𝘢𝘯𝘥 𝘍𝘢𝘤𝘦,” we explored how specific upper-body muscular rhythms influence circulation, oxygen delivery, and lymphatic balance in the head and brain.

This case brings that concept to life in a striking and unexpected way.

Keratoconus is typically understood as a structural condition — a thinning and distortion of the cornea. But for those living with it, the real challenge is often not just reduced vision… it’s instability.

Blur that comes and goes.

Clarity that fades as the day progresses.

And for some, vision that predictably collapses at the same time every day.

What makes this case different is not just improvement — but the complete disappearance of a long-standing daily pattern of visual failure.

In someone already living with one remaining eye, and facing the very real possibility of total vision loss, that shift is profound.

It raises an important question:

𝘞𝘩𝘢𝘵 𝘪𝘧 𝘷𝘪𝘴𝘶𝘢𝘭 𝘧𝘶𝘯𝘤𝘵𝘪𝘰𝘯 𝘪𝘴 𝘪𝘯𝘧𝘭𝘶𝘦𝘯𝘤𝘦𝘥 𝘢𝘴 𝘮𝘶𝘤𝘩 𝘣𝘺 𝘴𝘺𝘴𝘵𝘦𝘮 𝘴𝘵𝘢𝘣𝘪𝘭𝘪𝘵𝘺 𝘢𝘴 𝘪𝘵 𝘪𝘴 𝘣𝘺 𝘦𝘺𝘦 𝘴𝘵𝘳𝘶𝘤𝘵𝘶𝘳𝘦?

🌐 VEKTA.NET



https://ibooststudios.blogspot.com/2026/04/when-daily-vision-loss-disappears.html

In our earlier post, “ Why Neck and Shoulder Movement Is the Real ‘Pump’ for the Brain and Face ,” we explored how specific muscular rhyth...

31/03/2026

12/03/2026

𝗤𝘂𝗶𝗲𝘁𝗶𝗻𝗴 “𝗙𝗼𝗼𝗱 𝗡𝗼𝗶𝘀𝗲” — 𝗔 𝗠𝗲𝘁𝗮𝗯𝗼𝗹𝗶𝗰 𝗣𝗲𝗿𝘀𝗽𝗲𝗰𝘁𝗶𝘃𝗲

“Food noise” — the constant mental chatter about food, cravings, and snacking — is increasingly being addressed through medications such as 𝗦𝗲𝗺𝗮𝗴𝗹𝘂𝘁𝗶𝗱𝗲, which mimic 𝗚𝗹𝘂𝗰𝗮𝗴𝗼𝗻-𝗹𝗶𝗸𝗲 𝗽𝗲𝗽𝘁𝗶𝗱𝗲-𝟭 (𝗚𝗟𝗣-𝟭) to suppress appetite.

While these medications can be effective, they work by 𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹𝗹𝘆 𝗮𝗹𝘁𝗲𝗿𝗶𝗻𝗴 𝗮𝗽𝗽𝗲𝘁𝗶𝘁𝗲 𝘀𝗶𝗴𝗻𝗮𝗹𝗹𝗶𝗻𝗴, and can sometimes come with trade-offs such as dependency, muscle loss during weight reduction, mood effects, and other medical risks.

An interesting alternative perspective is emerging from muscle physiology.

Skeletal muscle is not just mechanical tissue — it is a powerful 𝗺𝗲𝘁𝗮𝗯𝗼𝗹𝗶𝗰 𝘀𝗶𝗴𝗻𝗮𝗹𝗹𝗶𝗻𝗴 𝗼𝗿𝗴𝗮𝗻. When activated intensely, muscles release myokines that influence glucose regulation, inflammation, brain signalling, and appetite control.

In practice, we are seeing something interesting during 𝗞𝗶𝗻𝗲𝗗𝗲𝗸 𝗔𝗜-𝗖𝗥𝗧 𝘀𝗲𝘀𝘀𝗶𝗼𝗻𝘀:
• A typical 𝟮𝟬-𝗺𝗶𝗻𝘂𝘁𝗲 𝘀𝗲𝘀𝘀𝗶𝗼𝗻 𝗼𝗻𝗰𝗲 𝗽𝗲𝗿 𝘄𝗲𝗲𝗸 can produce a rapid drop in elevated glucose levels immediately after exercise.
• Over several weeks, glucose levels often stabilize within or close to the healthy range.
• As metabolic signalling stabilizes, many participants spontaneously report:
– reduced sugar and carb cravings
– less snacking between meals
– stable energy throughout the day
– improved sleep and mood
– gradual body recomposition.

Importantly, the nutritional guidance is 𝗻𝗼𝘁 𝘀𝘁𝗿𝗶𝗰𝘁 𝗿𝗲𝘀𝘁𝗿𝗶𝗰𝘁𝗶𝗼𝗻.

Rather than telling people to eliminate carbs or sugars — which most people already know but struggle to sustain — the focus is simply on:
• increasing 𝗽𝗿𝗼𝘁𝗲𝗶𝗻 𝗶𝗻𝘁𝗮𝗸𝗲
• eating 𝗴𝗼𝗼𝗱 𝗾𝘂𝗮𝗹𝗶𝘁𝘆 𝗳𝗿𝘂𝗶𝘁𝘀 𝗮𝗻𝗱 𝘃𝗲𝗴𝗲𝘁𝗮𝗯𝗹𝗲𝘀 𝘄𝗵𝗲𝗻𝗲𝘃𝗲𝗿 𝗽𝗼𝘀𝘀𝗶𝗯𝗹𝗲

Interestingly, once metabolic signalling improves, 𝘁𝗵𝗲 𝗰𝗿𝗮𝘃𝗶𝗻𝗴𝘀 𝗳𝗼𝗿 𝘀𝘂𝗴𝗮𝗿𝘀 𝗮𝗻𝗱 𝗿𝗲𝗳𝗶𝗻𝗲𝗱 𝗰𝗮𝗿𝗯𝗼𝗵𝘆𝗱𝗿𝗮𝘁𝗲𝘀 𝗿𝗲𝗱𝘂𝗰𝗲 𝗼𝗻 𝘁𝗵𝗲𝗶𝗿 𝗼𝘄𝗻.

In other words, the body begins to 𝘀𝗲𝗹𝗳-𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗲 𝗮𝗽𝗽𝗲𝘁𝗶𝘁𝗲, rather than having it suppressed pharmacologically.

The emerging insight is simple but powerful:

𝗦𝗼𝗺𝗲𝘁𝗶𝗺𝗲𝘀 𝗾𝘂𝗶𝗲𝘁𝗶𝗻𝗴 𝗳𝗼𝗼𝗱 𝗻𝗼𝗶𝘀𝗲 𝗶𝘀 𝗹𝗲𝘀𝘀 𝗮𝗯𝗼𝘂𝘁 𝗳𝗶𝗴𝗵𝘁𝗶𝗻𝗴 𝗰𝗿𝗮𝘃𝗶𝗻𝗴𝘀, 𝗮𝗻𝗱 𝗺𝗼𝗿𝗲 𝗮𝗯𝗼𝘂𝘁 𝗿𝗲𝘀𝘁𝗼𝗿𝗶𝗻𝗴 𝗺𝗲𝘁𝗮𝗯𝗼𝗹𝗶𝗰 𝗯𝗮𝗹𝗮𝗻𝗰𝗲.

🌐 VEKTA.NET

Many people struggle with “food noise.” It’s the constant mental chatter about food: thinking about the next snack persistent sugar cravings...

01/03/2026

𝗟𝘂𝗽𝘂𝘀 / 𝗥𝗔 𝗖𝗮𝘀𝗲 𝗨𝗽𝗱𝗮𝘁𝗲

Johanna has been doing 20 minute KineDek sessions for four years — 10 months of consistent sessions twice weekly, a 16 month break, and then once-weekly sessions for the past 22 months.

Importantly, during the 1 year and 4 months that she did not train, she was providing round-the-clock care for her elderly mother, who was suffering from severe dementia, until her passing. Despite this prolonged and highly stressful period, 𝗵𝗲𝗿 𝗟𝘂𝗽𝘂𝘀 𝗮𝗻𝗱 𝗥𝗔 𝗱𝗶𝗱 𝗻𝗼𝘁 𝗿𝗲𝗰𝘂𝗿.

Her latest pathology results show 𝗻𝗼 𝗺𝗮𝗿𝗸𝗲𝗿𝘀 𝗶𝗻𝗱𝗶𝗰𝗮𝘁𝗶𝘃𝗲 𝗼𝗳 𝗮𝗰𝘁𝗶𝘃𝗲 𝗟𝘂𝗽𝘂𝘀 𝗼𝗿 𝗥𝗵𝗲𝘂𝗺𝗮𝘁𝗼𝗶𝗱 𝗔𝗿𝘁𝗵𝗿𝗶𝘁𝗶𝘀 (𝗥𝗔). Inflammation levels are within normal range, and importantly, there are 𝗻𝗼 𝘀𝗶𝗴𝗻𝘀 𝗼𝗳 𝗼𝗿𝗴𝗮𝗻 𝗱𝗮𝗺𝗮𝗴𝗲.

While previous RA-related degeneration caused significant hip damage — and she is scheduled for hip surgery this Wednesday — her systemic inflammatory profile is currently clear.

Johanna, all the best for your operation.
And a huge acknowledgement of your strength and courage in facing — and overcoming — these diseases.

Video from August 2022

🌐 VEKTA.NET

22/12/2025

𝟱𝟬%+ 𝗟𝗗𝗟 𝗖𝗵𝗼𝗹𝗲𝘀𝘁𝗲𝗿𝗼𝗹 𝗗𝗿𝗼𝗽 𝗶𝗻 𝟲 𝗠𝗼𝗻𝘁𝗵𝘀

In this interview, Denise (81 at the time of the interview) shares her remarkable health journey while living with diabetes and multiple cardiovascular conditions. Over a six-month period, her LDL cholesterol dropped significantly from 𝟵.𝟳 𝘁𝗼 𝟰.𝟮 (in the normal range), without the introduction of new medication.

Denise has a complex medical history, including 𝘁𝘄𝗼 𝗽𝗿𝗶𝗼𝗿 𝗵𝗲𝗮𝗿𝘁 𝗮𝘁𝘁𝗮𝗰𝗸𝘀, 𝗹𝗼𝗻𝗴-𝘀𝘁𝗮𝗻𝗱𝗶𝗻𝗴 𝘀𝗲𝘃𝗲𝗿𝗲 𝗵𝘆𝗽𝗲𝗿𝘁𝗲𝗻𝘀𝗶𝗼𝗻, 𝗮𝗻 𝗲𝗻𝗹𝗮𝗿𝗴𝗲𝗱 𝘃𝗲𝗻𝘁𝗿𝗶𝗰𝗹𝗲, 𝗖𝗵𝗿𝗼𝗻𝗶𝗰 𝗞𝗶𝗱𝗻𝗲𝘆 𝗗𝗶𝘀𝗲𝗮𝘀𝗲 (𝗖𝗞𝗗), 𝗮𝗿𝘁𝗵𝗿𝗶𝘁𝗶𝘀, 𝗮𝗻𝗱 𝗿𝗲𝗱𝘂𝗰𝗲𝗱 𝗺𝗼𝗯𝗶𝗹𝗶𝘁𝘆. Despite these challenges, she reports meaningful improvements in strength, stamina, mobility, and overall quality of life while doing just 𝗷𝘂𝘀𝘁 𝗼𝗻𝗲 𝗰𝗮𝗿𝗲𝗳𝘂𝗹𝗹𝘆 𝗺𝗼𝗱𝗲𝗿𝗮𝘁𝗲𝗱 𝟮𝟬-𝗺𝗶𝗻𝘂𝘁𝗲 𝗞𝗶𝗻𝗲𝗗𝗲𝗸 𝗔𝗜-𝗖𝗥𝗧 𝘀𝗲𝘀𝘀𝗶𝗼𝗻 𝗽𝗲𝗿 𝘄𝗲𝗲𝗸.

Importantly, KineDek sessions are 𝗻𝗼𝘁 𝗰𝗮𝗿𝗱𝗶𝗼𝘃𝗮𝘀𝗰𝘂𝗹𝗮𝗿𝗹𝘆 𝗶𝗻𝘁𝗲𝗻𝘀𝗲 and are adjusted to her condition. Although daily overexertion can still trigger hypertensive episodes due to her cardiac history, Denise reports that such spikes have 𝗻𝗼𝘁 𝗼𝗰𝗰𝘂𝗿𝗿𝗲𝗱 𝗱𝘂𝗿𝗶𝗻𝗴 𝗼𝗿 𝗶𝗺𝗺𝗲𝗱𝗶𝗮𝘁𝗲𝗹𝘆 𝗮𝗳𝘁𝗲𝗿 𝗞𝗶𝗻𝗲𝗗𝗲𝗸 𝘀𝗲𝘀𝘀𝗶𝗼𝗻𝘀.

Denise also notes that during this period she 𝗽𝗲𝗿𝘀𝗼𝗻𝗮𝗹𝗹𝘆 𝗰𝗵𝗼𝘀𝗲 𝘁𝗼 𝗱𝗶𝘀𝗰𝗼𝗻𝘁𝗶𝗻𝘂𝗲 𝗵𝗲𝗿 𝗰𝗵𝗼𝗹𝗲𝘀𝘁𝗲𝗿𝗼𝗹 𝗺𝗲𝗱𝗶𝗰𝗮𝘁𝗶𝗼𝗻 (statins), a decision made independently and not on medical advice. Any changes to prescribed medication should always be undertaken in consultation with a qualified medical professional.

This interview offers a real-world perspective on how a highly controlled, non-cardiovascular resistance approach may support health and functional outcomes in elderly individuals with complex chronic conditions.

➡️ 📚 𝙁𝙤𝙧 𝙖 𝙙𝙚𝙚𝙥𝙚𝙧 𝙙𝙞𝙫𝙚 𝙞𝙣𝙩𝙤 𝙩𝙝𝙚 𝙥𝙝𝙮𝙨𝙞𝙤𝙡𝙤𝙜𝙞𝙘𝙖𝙡 𝙢𝙚𝙘𝙝𝙖𝙣𝙞𝙨𝙢 𝙖𝙩 𝙥𝙡𝙖𝙮, 𝙫𝙞𝙨𝙞𝙩t: https://bit.ly/44FgfK4

🌐 VEKTA.NET

12/12/2025

𝗖𝗼𝘂𝗹𝗱 𝘁𝗵𝗲𝗿𝗲 𝗯𝗲 𝗮𝗻𝗼𝘁𝗵𝗲𝗿 𝗮𝗻𝗴𝗹𝗲 𝘁𝗼 𝘂𝗻𝗱𝗲𝗿𝘀𝘁𝗮𝗻𝗱𝗶𝗻𝗴 𝗔𝗹𝘇𝗵𝗲𝗶𝗺𝗲𝗿’𝘀—𝗼𝗻𝗲 𝗿𝗼𝗼𝘁𝗲𝗱 𝗺𝗼𝗿𝗲 𝗶𝗻 𝘀𝘆𝘀𝘁𝗲𝗺𝗶𝗰 𝗽𝗵𝘆𝘀𝗶𝗼𝗹𝗼𝗴𝘆 𝘁𝗵𝗮𝗻 𝘄𝗲’𝘃𝗲 𝗽𝗿𝗲𝘃𝗶𝗼𝘂𝘀𝗹𝘆 𝗮𝗽𝗽𝗿𝗲𝗰𝗶𝗮𝘁𝗲𝗱?

A recent 20-month case using the KineDek AI-CRT “Brain-Bombing” Protocol has revealed something unusual in a 7+ year advanced Alzheimer’s case:
𝘴𝘦𝘷𝘦𝘳𝘦 𝘴𝘵𝘳𝘶𝘤𝘵𝘶𝘳𝘢𝘭 𝘣𝘳𝘢𝘪𝘯 𝘥𝘢𝘮𝘢𝘨𝘦, 𝘺𝘦𝘵 𝘤𝘰𝘮𝘱𝘭𝘦𝘵𝘦𝘭𝘺 𝘯𝘰𝘳𝘮𝘢𝘭𝘪𝘴𝘦𝘥 𝘴𝘺𝘴𝘵𝘦𝘮𝘪𝘤 𝘣𝘪𝘰𝘮𝘢𝘳𝘬𝘦𝘳𝘴

✅ No inflammation markers.
✅ No metabolic dysfunction.
✅ No biochemical signature of ongoing neurodegeneration.


Alongside this, we’ve seen:

✅ a persistent lift in mood from the very first session,
✅ stabilisation rather than decline, and
✅ a recent, unexpected improvement in spoken sentence formation.


These findings don’t suggest cognitive reversal — but they do raise an important question:

𝘐𝘧 𝘈𝘐-𝘊𝘙𝘛 𝘤𝘢𝘯 𝘴𝘶𝘱𝘱𝘳𝘦𝘴𝘴 𝘵𝘩𝘦 𝘴𝘺𝘴𝘵𝘦𝘮𝘪𝘤 𝘥𝘳𝘪𝘷𝘦𝘳𝘴 𝘰𝘧 𝘯𝘦𝘶𝘳𝘰𝘥𝘦𝘨𝘦𝘯𝘦𝘳𝘢𝘵𝘪𝘰𝘯 𝘦𝘷𝘦𝘯 𝘪𝘯 𝘭𝘢𝘵𝘦-𝘴𝘵𝘢𝘨𝘦 𝘈𝘭𝘻𝘩𝘦𝘪𝘮𝘦𝘳’𝘴, 𝘸𝘩𝘢𝘵 𝘮𝘪𝘨𝘩𝘵 𝘵𝘩𝘪𝘴 𝘮𝘦𝘢𝘯 𝘧𝘰𝘳 𝘱𝘳𝘦𝘷𝘦𝘯𝘵𝘪𝘰𝘯 𝘢𝘯𝘥 𝘦𝘢𝘳𝘭𝘺-𝘰𝘯𝘴𝘦𝘵 𝘥𝘪𝘴𝘦𝘢𝘴𝘦?

This case offers a valuable signal — one that may help us understand how shifting the body’s physiological environment can influence the brain’s long-term trajectory.

Here’s the full write-up, including possible mechanisms, early implications, and why this deserves careful clinical exploration.

🌐 VEKTA.NET

How 20 months of KineDek AI-CRT sessions produced unexpected systemic improvements—even when brain scans still show structural damage Pict...

01/12/2025

𝗖𝗮𝘀𝗲 𝗦𝗽𝗼𝘁𝗹𝗶𝗴𝗵𝘁: 𝗥𝗵𝗲𝘂𝗺𝗮𝘁𝗼𝗶𝗱 𝗔𝗿𝘁𝗵𝗿𝗶𝘁𝗶𝘀 𝗶𝗻 𝗥𝗲𝗺𝗶𝘀𝘀𝗶𝗼𝗻 𝗔𝗳𝘁𝗲𝗿 𝟯 𝗞𝗶𝗻𝗲𝗗𝗲𝗸 𝗦𝗲𝘀𝘀𝗶𝗼𝗻𝘀

When 35-year-old Tasha began experiencing severe pain and inflammation across her hands, neck, back, knees, and feet, her doctors suspected early-stage rheumatoid arthritis (RA). Bloodwork confirmed elevated inflammatory markers and irregular thyroid activity.

Remarkably, 𝘄𝗶𝘁𝗵𝗶𝗻 𝟮𝟰 𝗵𝗼𝘂𝗿𝘀 𝗼𝗳 𝗵𝗲𝗿 𝗳𝗶𝗿𝘀𝘁 𝗞𝗶𝗻𝗲𝗗𝗲𝗸 𝘀𝗲𝘀𝘀𝗶𝗼𝗻, 𝗳𝗼𝗹𝗹𝗼𝘄-𝘂𝗽 𝘁𝗲𝘀𝘁𝘀 𝘀𝗵𝗼𝘄𝗲𝗱 𝗻𝗼𝗿𝗺𝗮𝗹𝗶𝘇𝗲𝗱 𝗶𝗻𝗳𝗹𝗮𝗺𝗺𝗮𝘁𝗼𝗿𝘆 𝗺𝗮𝗿𝗸𝗲𝗿𝘀 𝗮𝗻𝗱 𝘁𝗵𝘆𝗿𝗼𝗶𝗱 𝗳𝘂𝗻𝗰𝘁𝗶𝗼𝗻. By her third session, her pain was no more, and she remained symptom-free — entering a state of remission.

This pattern reflects what has been observed in other RA cases using the KineDek AI-CRT protocol: 𝘳𝘢𝘱𝘪𝘥 𝘱𝘢𝘪𝘯 𝘳𝘦𝘥𝘶𝘤𝘵𝘪𝘰𝘯 𝘢𝘯𝘥 𝘮𝘦𝘢𝘴𝘶𝘳𝘢𝘣𝘭𝘦 𝘱𝘩𝘺𝘴𝘪𝘰𝘭𝘰𝘨𝘪𝘤𝘢𝘭 𝘳𝘦𝘤𝘢𝘭𝘪𝘣𝘳𝘢𝘵𝘪𝘰𝘯 𝘸𝘪𝘵𝘩𝘪𝘯 𝘥𝘢𝘺𝘴, 𝘴𝘶𝘨𝘨𝘦𝘴𝘵𝘪𝘯𝘨 𝘢 𝘱𝘰𝘵𝘦𝘯𝘵𝘪𝘢𝘭 𝘦𝘢𝘳𝘭𝘺-𝘪𝘯𝘵𝘦𝘳𝘷𝘦𝘯𝘵𝘪𝘰𝘯 𝘱𝘢𝘵𝘩𝘸𝘢𝘺 𝘧𝘰𝘳 𝘪𝘯𝘧𝘭𝘢𝘮𝘮𝘢𝘵𝘰𝘳𝘺 𝘤𝘰𝘯𝘥𝘪𝘵𝘪𝘰𝘯𝘴.

➡️ 📚 𝙁𝙤𝙧 𝙖 𝙙𝙚𝙚𝙥𝙚𝙧 𝙙𝙞𝙫𝙚, 𝙫𝙞𝙨𝙞𝙩t: https://bit.ly/4pMfyXD

🌐 VEKTA.NET